Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Get Free Report) traded down 5.7% on Friday . The company traded as low as $120.11 and last traded at $120.16. 383,391 shares changed hands during mid-day trading, a decline of 83% from the average session volume of 2,227,115 shares. The stock had previously closed at $127.38.
Direxion Daily S&P Biotech Bull 3x Shares Stock Down 4.9 %
The stock has a 50 day moving average price of $129.61 and a two-hundred day moving average price of $121.73.
Institutional Investors Weigh In On Direxion Daily S&P Biotech Bull 3x Shares
A number of institutional investors have recently modified their holdings of LABU. Headlands Technologies LLC acquired a new position in Direxion Daily S&P Biotech Bull 3x Shares during the 2nd quarter worth $68,000. SG Americas Securities LLC grew its stake in Direxion Daily S&P Biotech Bull 3x Shares by 82.8% during the 2nd quarter. SG Americas Securities LLC now owns 2,142 shares of the company’s stock worth $243,000 after purchasing an additional 970 shares in the last quarter. Foundations Investment Advisors LLC grew its stake in Direxion Daily S&P Biotech Bull 3x Shares by 25.3% during the 2nd quarter. Foundations Investment Advisors LLC now owns 4,087 shares of the company’s stock worth $464,000 after purchasing an additional 825 shares in the last quarter. Sheaff Brock Investment Advisors LLC acquired a new position in Direxion Daily S&P Biotech Bull 3x Shares during the 4th quarter worth $488,000. Finally, Jump Financial LLC acquired a new position in Direxion Daily S&P Biotech Bull 3x Shares during the 4th quarter worth $521,000.
Direxion Daily S&P Biotech Bull 3x Shares Company Profile
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
Read More
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3x Shares
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Is Merck Stock Undervalued After Its Colossal Earnings Growth?
- Using the MarketBeat Dividend Yield Calculator
- Top 5 ETFs for Every Investor: From Semiconductors to Defense
- Investing in Travel Stocks Benefits
- Blade Air Mobility: This Under-the-Radar Stock Could Double Soon
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.